Summary & Overview
CPT 3290F: Undefined Clinical Service
CPT code 3290F is a Current Procedural Terminology (CPT) code with no descriptive summary provided in the source material. As a CPT-designated code, it corresponds to a defined clinical service, procedure, or performance measure used across U.S. health care billing. Understanding the meaning and billing rules for this code matters nationally because CPT codes drive claims processing, payment policy, quality measurement, and care documentation for providers, payers, and regulators.
This publication frames national implications and payer coverage context for major payers: Aetna, Blue Cross Blue Shield, Cigna Health, UnitedHealthcare, and Medicare. Readers will find an outline of what a complete analysis would cover, including typical claims benchmarks, coding guidance, potential policy updates that affect reimbursement and reporting, and the clinical context necessary to interpret the code’s use. Where specific input data are missing, the report clearly indicates unavailable items.
Intended as an executive briefing, the summary prepares coding managers, revenue cycle leaders, and policy analysts to seek the full clinical descriptor and payer-specific guidance for 3290F. The document highlights the next steps for a national audience: obtaining the definitive CPT definition, mapping related clinical documentation, and reviewing payer policy manuals for coverage and billing requirements.
Billing Code Overview
CPT code 3290F has no summary available in the source description. Based on the code designation, this entry represents a specific CPT-defined clinical or performance item; the precise clinical action or measurement is not provided in the input. Service type: Data not available in the input. Typical site of service: Data not available in the input.
Clinical & Coding Specifications
Clinical Context
A typical patient is an adult referred for outpatient diagnostic and/or therapeutic bronchoscopy with possible transbronchial biopsy due to new or worsening respiratory symptoms (cough, hemoptysis, unexplained dyspnea) and radiographic lung findings (pulmonary nodule, focal consolidation, or diffuse interstitial change). The workflow begins with pre-procedure evaluation including history, medication review (anticoagulant status), informed consent, and chest imaging review. On procedure day the patient presents to an ambulatory surgical center or hospital endoscopy suite. Moderate sedation or monitored anesthesia care is administered depending on comorbidities and anticipated complexity. The bronchoscopist performs flexible bronchoscopy to visualize airways, obtain bronchial washings, brushings, and transbronchial biopsy samples as indicated. Specimens are sent to pathology and microbiology. Post-procedure monitoring occurs in a recovery area; discharge or inpatient admission is based on findings and immediate complications (e.g., pneumothorax, bleeding). Documentation includes indication, pre-procedure assessment, sedation details, procedure steps, number and location of biopsies, specimen disposition, and post-procedure status.
Coding Specifications
| Modifier | Description | When to Use |
|---|---|---|
25 | Significant, separately identifiable evaluation and management service by the same physician on the same day of the procedure | Use when a distinct E/M visit is performed and documented on the same day as the procedure. |
| | Multiple procedures | Use when more than one procedure is billed during the same session and payer requires a multiple procedure modifier.